New Hope for Relapsed Pleural Mesothelioma?
There is new evidence that adding a drug called vorinostat to immunotherapy might help relapsed pleural mesothelioma patients. The new…
-
-
Effect of Chemotherapy on Immunotherapy for Mesothelioma
Belgian scientists say they are still not sure about the effect of chemotherapy on immunotherapy for mesothelioma. They reached that… -
New Mesothelioma Immunotherapy Trial Now Underway at Baylor
Cancer researchers at Baylor College of Medicine have launched a new mesothelioma immunotherapy trial. The trial combines the cancer drug… -
Mesothelioma Immunotherapy Drug Keytruda Gets a Boost from Opdivo Study
The company that makes a promising new mesothelioma immunotherapy drug got a boost from a competitor’s study this week. The… -
Immunotherapy Vaccine for Mesothelioma Shows Promise in Combination Treatment
A bacteria-based immunotherapy vaccine for mesothelioma may improve the odds of surviving the disease by boosting the effects of chemotherapy. … -
Palliative Radiotherapy for Mesothelioma Produces “Substantial Treatment Response”
Doctors in Pennsylvania may have found a way to boost the effectiveness of palliative radiotherapy for pleural mesothelioma. Palliative radiotherapy… -
Chemoimmunotherapy Called “Next Frontier” for Mesothelioma Cancer
Mesothelioma researchers in Australia are calling the combination of chemotherapy and immunotherapy the “next frontier” in the treatment of mesothelioma… -
Chemotherapy | Immunotherapy | New Drugs | New Studies | Research | Treatments | Virus
Combination Mesothelioma Therapy Begins Pivotal Trial
A combination mesothelioma therapy that showed promise in early trials is finally being studied on a larger scale. The power-packed… -
New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy
A Dutch company has recruited the first patients into a pivotal mesothelioma clinical trial of autologous dendritic cells. Dendritic cells… -
PARP Inhibitors Could Enhance Immunotherapy Response in Mesothelioma
A new study suggests that drugs known as PARP inhibitors may enhance immunotherapy response in mesothelioma patients. According to a…
